Gilead Sciences, Inc. Portfolio Stock Holdings
According to the SEC 13F filed on August 3, 2026, Gilead Sciences, Inc. disclosed 5 stock positions valued at approximately $1.65B as of quarter-end June 30, 2026. The largest holdings include Arcus Biosciences Inc., Lakefront Biotherapeutics, and Assembly Biosciences Inc..
- Report Period
- June 30, 2026
- No. of Stocks
- 5
- Portfolio Value
- $1.65B
Holdings by Sector
Gilead Sciences, Inc. Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| Arcus Biosciences Inc. | RCUS | Healthcare | 58.76% | 31,424,760 | - | - | $968,825,351 |
| Lakefront Biotherapeutics | GLPG | Healthcare | 30.34% | 16,707,477 | - | - | $500,157,715 |
| Assembly Biosciences Inc. | ASMB | Healthcare | 8.30% | 4,977,089 | +471,698 | +10.47% | $136,770,406 |
| Kyverna Therapeutics Inc. | KYTX | Healthcare | 2.23% | 4,126,119 | - | - | $36,763,720 |
| Xilio Therapeutics Inc. | XLO | Healthcare | 0.38% | 650,389 | - | - | $6,230,727 |
Showing 5 of 5 holdings in the latest reporting period.